<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-5664917384681228257</id><updated>2011-07-08T04:13:35.306-07:00</updated><title type='text'>August 2009 icuroom.net archive</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>31</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-293203146675573102</id><published>2009-08-31T13:24:00.000-07:00</published><updated>2009-08-30T16:35:52.603-07:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday August 31, 2009&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Hypertension management in perioperative period&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Patients undergoing surgical procedures especially cardiac surgery can experience hypertensive urgencies (ie. severe blood pressure elevations without end organ dysfunction) or hypertensive emergencies (i.e. severe blood pressure elevations BP &gt;180/110 mmHg with impending or progressive end organ damage), before, during, or after the procedure.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;There are several continuous infusion options to control the hypertensive crisis:&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Esmolol (ultra-short action cardioselective b blocker)&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Preferred use:&lt;/span&gt;&lt;/em&gt; Acute myocardial ischemia, ideal choice when CO, HR, and BP are increased&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Dose&lt;/em&gt;&lt;/span&gt;: LD 500-1000 microgram/kg over 1 minute; Infusion starting at 50 microgram/kg/min, titrating up to max 300 microgram/kg/min as needed to maintain BP&lt;br /&gt;&lt;br /&gt;Rapid onset of 60 seconds, duration of action 10-20 minutes&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Comment&lt;/span&gt;&lt;/em&gt;: Caution should be used in patient with COPD&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Nicardipine (short-acting dihydropyridine CCB)&lt;/strong&gt;&lt;/span&gt; &lt;/span&gt;&lt;br /&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Preferred use&lt;/span&gt;&lt;/em&gt;: Acute myocardial ischemia, acute renal failure, acute ischemic stroke/intracerebral bleed, eclampsia/preeclampsia, hypertensive encephalopathy, sympathetic crisis/cocaine overdose&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Dose:&lt;/em&gt;&lt;/span&gt; 5 mg/hr increasing by 2.5mg/hr every 5 minutes to maximum 15mg/hr until BP achieved. It has been seen that doses have been titrated up to 30-45 mg/hr.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Comment:&lt;/span&gt;&lt;/em&gt; Increases SV and coronary blood flow&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Labetalol (a1 and non selective b1 &amp;shy;blocker)&lt;/span&gt;&lt;/strong&gt; &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Preferred use&lt;/span&gt;&lt;/em&gt;: acute aortic dissection, acute myocardial ischemia, acute ischemic stroke/intracerebral bleed, eclampsia/preeclampsia hypertensive encephalopathy&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Dose:&lt;/span&gt;&lt;/em&gt; May be given as bolus doses or continuous infusion, Bolus: LD 20mg IV, with incremental dose of 20-80mg every 10 minutes until BP achieved, Continuous IV: LD 20mg IV, infusion 1-2 mg/min titrated up until BP achieved, Max dose 300mg over 24 hours&lt;br /&gt;&lt;br /&gt;Onset of action 2-5 minutes, duration of action 2-4 hours&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Comment:&lt;/span&gt;&lt;/em&gt; Reduces SVR without reducing total peripheral blood flow. Caution should be taken in patients with HF. Avoid in patients with severe sinus bradycardia, heart block greater than 1st degree, and asthma. &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Nitroglycerin (direct vasodilator or peripheral capacitance and resistance vessels)&lt;/span&gt;&lt;/strong&gt; &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Dose&lt;/span&gt;&lt;/em&gt;: 5 microgram/min every 5 minutes to 20 microgram/min. If not response at 20 microgram/min then increase by 10 microgram/min to max dose of 200 microgram/min, Onset of action 2-5 minutes, duration 10-20 minutes&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Comments:&lt;/span&gt;&lt;/em&gt; Reduces BP by reducing preload and CO. Should not be used in patients with cerebral compromised or renal insufficiency&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Sodium nitroprusside (arterial and venous vasodilator)&lt;/span&gt;&lt;/strong&gt; &lt;/p&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Preferred use:&lt;/em&gt;&lt;/span&gt; hypertensive emergency without cerebral compromise or renal/hepatic insufficiency&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;Dose:&lt;/span&gt; 0.5 microgram/kg/min titrated as tolerated, max 2 microgram/kg/min Onset of action is seconds, duration of action 1-2 minutes&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Disadvantages&lt;/em&gt;&lt;/span&gt;: not recommended for patients who have decreased cerebral blood flow, accumulation of cyanide and thiocyanate&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Comment&lt;/em&gt;:&lt;/span&gt; Duration of use should be limited to 72 hours due to the potential for toxicity&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference:&lt;br /&gt;&lt;br /&gt;Varon J. Vascular Health and Risk Management. 2008;4(3):615.&lt;br /&gt;Varon J. Drugs. 2008;68(3):283&lt;/span&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-293203146675573102?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/293203146675573102/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-31-2009-hypertension.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/293203146675573102'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/293203146675573102'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-31-2009-hypertension.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-2871222652135414268</id><published>2009-08-30T07:37:00.000-07:00</published><updated>2009-08-30T07:42:22.080-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Sunday August 30, 2009&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;"Permissive Undernutrition" ! / CRRT&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Interesting lecture from Paul Marik, MD, FCCM, FCCP. &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Click on link below, (Lecture length: 12 minutes 15 Seconds)&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;a href="http://crrtonline.com/lectures/40_Marik_AV.html"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Nutrition in the Critically Ill-How much is enough? "Permissive Undernutrition"&lt;/span&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Editors' note&lt;/em&gt;&lt;/span&gt;: Above lecture is located at a very informative site on CRRT (continuous renal replacement therapy)&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;a href="http://crrtonline.com/login.php"&gt;&lt;span style="color:#660000;"&gt;CRRTonline.com&lt;/span&gt;&lt;/a&gt; &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="font-size:85%;"&gt;&lt;em&gt;You may have to register (free)&lt;/em&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;This site is a full portal of information on CRRT including &lt;/div&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;ul&gt;&lt;/span&gt;&lt;/strong&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Protocols &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Case Management &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Published Literature &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;System Based Approaches to CRRT &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Utilizing CRRT/Machine Set-up &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Fluid Management &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Drug Management &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Templates/Flow Sheets &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Calculators &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Existing Products/Links &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;li&gt;&lt;div align="left"&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Solution/Product Comparisons &lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p align="left"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;icuroom.net has no financial relationship with any instiution or industry. Information provided here is solely for educational purpose.&lt;/span&gt;&lt;/em&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-2871222652135414268?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/2871222652135414268/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-30-2009-permissive.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/2871222652135414268'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/2871222652135414268'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-30-2009-permissive.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-5439480703467044936</id><published>2009-08-29T08:02:00.000-07:00</published><updated>2009-08-29T08:02:00.185-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday August 29, 2009&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Supraclavicular Subclavian Vein Catheterization: The Forgotten Central Line?&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;Advantages of the supraclavicular approach over the infraclavicular technique include:&lt;br /&gt;&lt;br /&gt;a well-defined insertion landmark (the clavisternomastoid angle);&lt;br /&gt;a shorter distance from skin to vein;&lt;br /&gt;a larger target area;&lt;br /&gt;a straighter path to the superior vena cava; less proximity to the lung; and&lt;br /&gt;fewer complications of pleural or arterial puncture.&lt;br /&gt;The supraclavicular approach less often necessitates interruption of CPR or tube thoracostomy than the infraclavicular method.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;em&gt;(See reference article below)&lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://3.bp.blogspot.com/_-p7DcK-ba74/SpiagKNMZnI/AAAAAAAAAlk/C56m84Ud9Os/s1600-h/scvein.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 389px; DISPLAY: block; HEIGHT: 400px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5375216032552871538" border="0" alt="" src="http://3.bp.blogspot.com/_-p7DcK-ba74/SpiagKNMZnI/AAAAAAAAAlk/C56m84Ud9Os/s400/scvein.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference: click to get article&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2691520"&gt;&lt;em&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Supraclavicular Subclavian Vein Catheterization: The Forgotten Central Line&lt;/span&gt;&lt;/em&gt;&lt;/a&gt;&lt;em&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - West J Emerg Med. 2009 May; 10(2): 110–114&lt;/span&gt;&lt;/em&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-5439480703467044936?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/5439480703467044936/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-29-2009-supraclavicular.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/5439480703467044936'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/5439480703467044936'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-29-2009-supraclavicular.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_-p7DcK-ba74/SpiagKNMZnI/AAAAAAAAAlk/C56m84Ud9Os/s72-c/scvein.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-8644151880471396452</id><published>2009-08-28T18:11:00.000-07:00</published><updated>2009-08-28T18:11:00.346-07:00</updated><title type='text'></title><content type='html'>&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;&lt;strong&gt;Friday August 28, 2009&lt;/strong&gt; &lt;em&gt;(pediatric pearl)&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;&lt;strong&gt;Fetal haemoglobin&lt;/strong&gt;&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Fetal haemoglobin (which is present in fetal life and up to 3 months following birth) is not able to deliver oxygen to the tissues as efficiently as normal haemoglobin because the oxy-haemoglobin dissociation curve is shifted to the left causing oxygen to be released less readily. Neonates have a higher haemoglobin concentration (17 g/dl) and blood volume and this together with the increased cardiac output compensates for the decreased release of oxygen from haemoglobin in the tissues. Replacement of fetal haemoglobin with adult haemoglobin begins at 2-3 months of age and this period is known as physiological anaemia as haemoglobin concentrations may fall to 11 g/dl. Anaemia sufficient to jeopardise oxygen carrying capacity of the blood is possible if the haemoglobin concentration is less than 13 g/dl in the newborn and less than 10 g/dl in the infant under 6 months of age.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-8644151880471396452?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/8644151880471396452/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/friday-august-28-2009-pediatric-pearl.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/8644151880471396452'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/8644151880471396452'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/friday-august-28-2009-pediatric-pearl.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-2523774256963562994</id><published>2009-08-27T09:04:00.000-07:00</published><updated>2009-08-27T09:04:00.231-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday August 27, 2009&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;div align="center"&gt;&lt;span style="color:#990000;"&gt;&lt;strong&gt;Fecal loading in the cecum&lt;br /&gt;What is your diagnosis?&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/div&gt; &lt;a href="http://1.bp.blogspot.com/_-p7DcK-ba74/SpYGApxqReI/AAAAAAAAAlc/zc3nR-usWDo/s1600-h/en_07f1.jpg"&gt;&lt;br /&gt;&lt;a href="http://1.bp.blogspot.com/_-p7DcK-ba74/SpYGApxqReI/AAAAAAAAAlc/zc3nR-usWDo/s1600-h/en_07f1.jpg"&gt;&lt;p&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 400px; DISPLAY: block; HEIGHT: 298px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5374489813597177314" border="0" alt="" src="http://1.bp.blogspot.com/_-p7DcK-ba74/SpYGApxqReI/AAAAAAAAAlc/zc3nR-usWDo/s400/en_07f1.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Answer:&lt;/span&gt; Acute Appendicitis&lt;br /&gt;&lt;br /&gt;Image of fecal loading in the cecum presented a sensitivityof 97% for acute appendicitis. The frequency of this sign is higher than the frequency of other signs included as part of the clinical, laboratory and even imaging workups for patients with acute appendicitis.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference:&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.scielo.br/scielo.php?pid=S0100-39842007000400007&amp;amp;script=sci_arttext&amp;amp;tlng=en"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Radiographic image of fecal loading in the cecum as a diagnostic sign of acute appendicitis&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Radiol Bras vol.40 no.4 São Paulo July/Aug. 2007&lt;/span&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-2523774256963562994?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/2523774256963562994/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/thursday-august-27-2009-fecal-loading.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/2523774256963562994'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/2523774256963562994'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/thursday-august-27-2009-fecal-loading.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_-p7DcK-ba74/SpYGApxqReI/AAAAAAAAAlc/zc3nR-usWDo/s72-c/en_07f1.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-1800422052147182398</id><published>2009-08-26T06:09:00.000-07:00</published><updated>2009-08-26T16:44:06.799-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Wednesday August 26, 2009&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#990000;"&gt;Contamination of Portable Radiograph Equipment With Resistant Bacteria in the ICU&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Background:&lt;/span&gt; Approximately 15% of nosocomial infections in the ICU result from spread of bacteria on caregivers' hands. The routine chest radiograph provides an unexamined opportunity for bacterial spread: close contact with each patient and sequential examination of ICU patients. This study examined infection control procedures performed during routine chest radiographs, assessed whether resistant bacteria were transferred to the radiograph machine, and determined whether improved infection control practices by radiograph technicians could reduce bacterial transfer.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Methods&lt;/span&gt;: Radiograph technicians were observed performing chest radiographs on all ICU patients. Culture specimens were taken from the radiograph machine. An educational intervention directed at technicians was instituted, and its effect on infection control and machine contamination was measured.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Results&lt;/span&gt;: Surveillance of 173, 113, and 120 chest radiographs during observation, intervention, and follow-up periods was performed. &lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;Adequate infection control was practiced during the performance of 2 of 173 observation period radiographs (1%), 48 of 113 intervention period radiographs (42%), and 12 of 120 follow-up period radiographs (10%) [follow-up vs intervention and observation periods]. &lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Radiograph machine surface culture samples yielded resistant Gram-negative bacteria on 12 of 30 occasions (39%), 0 of 29 occasions, and 7 of 14 occasions (50%), respectively, for the observation, intervention, and follow-up periods.&lt;br /&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Conclusion:&lt;/span&gt; Multiresistant bacteria are frequently transferred from patients to the radiograph machine in the presence of poor infection control practices, and may be a source of cross-infection/colonization. Improved infection control practices decrease the occurrence of resistant organisms on the radiograph equipment. Radiograph technicians should be included in efforts to improve infection control measures.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference:&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://www.chestjournal.org/content/136/2/426.abstract"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Contamination of Portable Radiograph Equipment With Resistant Bacteria in the ICU&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - CHEST August 2009 vol. 136 no. 2 426-432&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-1800422052147182398?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/1800422052147182398/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/wednesday-august-26-2009-contamination.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/1800422052147182398'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/1800422052147182398'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/wednesday-august-26-2009-contamination.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-7283156448275070898</id><published>2009-08-25T17:02:00.000-07:00</published><updated>2009-08-25T17:05:15.616-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Tuesday August 25, 2009&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Adenosine for wide-complex tachycardia: Efficacy and safety&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Objectives:&lt;/span&gt; To determine whether adenosine is useful and safe as a diagnostic and therapeutic agent for patients with undifferentiated wide QRS complex tachycardia. The etiology of sustained monomorphic wide QRS complex tachycardia is often uncertain acutely.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Design:&lt;/span&gt; A retrospective observational study with emergency visits at nine urban hospitals. Consecutive patients treated with adenosine for regular wide QRS complex tachycardia between 1991 and 2006.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A positive response:&lt;/span&gt; was defined as an observed change in rhythm including temporary atrioventricular conduction block or tachycardia termination.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;A primary adverse event:&lt;/span&gt; was defined as emergent electrical or medical therapy instituted in response to an adverse adenosine effect.&lt;br /&gt;&lt;br /&gt;&lt;em&gt;A rhythm diagnosis was made in each case. The characteristics of adenosine administration as a test for a supraventricular as opposed to ventricular tachycardia were determined, and the adverse event rates were calculated.&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Results:&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;A total of 197 patients were included: 104 (90%) of 116 and two (2%) of 81 supraventricular tachycardia and ventricular tachycardia patients demonstrated a response to adenosine, respectively. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;The odds of supraventricular tachycardia increased by a factor of 36 after a positive response to adenosine. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;The odds of ventricular tachycardia increased by a factor of 9 when there was no response to adenosine. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;The rate of primary adverse events for patients with supraventricular tachycardia and ventricular tachycardia was 0 (0%) of 116 and 0 (0%) of 81 respectively.&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Conclusions:&lt;/span&gt; Adenosine is useful and safe as a diagnostic and therapeutic agent for patients with regular wide QRS complex tachycardia.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference:&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;a href="http://journals.lww.com/ccmjournal/Abstract/2009/09000/Adenosine_for_wide_complex_tachycardia__Efficacy.3.aspx"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Adenosine for wide-complex tachycardia: Efficacy and safety&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Critical Care Medicine: September 2009 - Volume 37 - Issue 9 - pp 2512-2518&lt;/span&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-7283156448275070898?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/7283156448275070898/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/tuesday-august-25-2009-adenosine-for.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/7283156448275070898'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/7283156448275070898'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/tuesday-august-25-2009-adenosine-for.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-557136405329177317</id><published>2009-08-24T10:27:00.000-07:00</published><updated>2009-08-24T10:27:00.139-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Monday August 24, 2009&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;What are the 3 mechanisms by which lactulose improve hepatic encephelopathy?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Answer:&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;The conversion of Lactulose to lactic acid results in acidification of the gut lumen. This favors conversion of NH4 + to NH3 and the passage of NH3 from tissues into the lumen. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Gut acidification inhibits ammoniagenic coliform bacteria, leading to increased levels of nonammoniagenic lactobacilli. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Lactulose also works as a cathartic, reducing colonic bacterial load.&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-557136405329177317?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/557136405329177317/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-24-2009-q-what-are-3.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/557136405329177317'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/557136405329177317'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-24-2009-q-what-are-3.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-2342146455240939361</id><published>2009-08-23T21:24:00.000-07:00</published><updated>2009-08-23T21:24:00.688-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday August 23, 2009 &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;p&gt;&lt;strong&gt;&lt;/strong&gt; &lt;/p&gt;&lt;p align="center"&gt;&lt;strong&gt;Managing chest tube (drainage system)&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;object width="425" height="344"&gt;&lt;param name="movie" value="http://www.youtube.com/v/y1gaC3yfhvw&amp;amp;color1=0xb1b1b1&amp;amp;color2=0xcfcfcf&amp;amp;hl=en&amp;amp;feature=player_embedded&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;param name="allowScriptAccess" value="always"&gt;&lt;embed src="http://www.youtube.com/v/y1gaC3yfhvw&amp;color1=0xb1b1b1&amp;color2=0xcfcfcf&amp;hl=en&amp;feature=player_embedded&amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" allowscriptaccess="always" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-2342146455240939361?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/2342146455240939361/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-23-2009-managing-chest.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/2342146455240939361'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/2342146455240939361'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-23-2009-managing-chest.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-4713040011754571707</id><published>2009-08-22T07:33:00.001-07:00</published><updated>2009-08-22T07:35:21.297-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday August 22, 2009&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Case:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;69 year old male admitted to ICU for community acquired pneumonia and did well with treatment. Over last 24 hours received Thorazine for persistent hiccups. While revewing morning EKG, you noticed following changes? &lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;p&gt;&lt;a href="http://2.bp.blogspot.com/_-p7DcK-ba74/SpABs1HIijI/AAAAAAAAAlU/8XpLx2FiC2w/s1600-h/phenothiazine.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 83px; DISPLAY: block; HEIGHT: 59px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5372796225135872562" border="0" alt="" src="http://2.bp.blogspot.com/_-p7DcK-ba74/SpABs1HIijI/AAAAAAAAAlU/8XpLx2FiC2w/s400/phenothiazine.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Answer:&lt;/span&gt; Phenothiazines induced EKG changes.&lt;br /&gt;&lt;br /&gt;Phenothiazines induced EKG changes seen in approximately 50% of patients receiving "therapeutic" doses. &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Mimics hypokalemia &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Prominent U waves &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Low amplitude T waves or T wave inversion &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;ST segment depression &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Prolonged QT interval&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;em&gt;&lt;span style="color:#000000;"&gt;Phenothiazines include Chlorpromazine hydrochloride (Thorazine), Prochlorperazine (Compazine), Promethazine hydrochloride (Phenergan) , Thioridazine hydrochloride (Mellaril) , Trifluoperazine hydrochloride (Stelazine) and others&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-4713040011754571707?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/4713040011754571707/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-22-2009-case-69-year.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/4713040011754571707'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/4713040011754571707'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-22-2009-case-69-year.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_-p7DcK-ba74/SpABs1HIijI/AAAAAAAAAlU/8XpLx2FiC2w/s72-c/phenothiazine.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-483055091330360512</id><published>2009-08-21T06:33:00.000-07:00</published><updated>2009-08-21T06:33:00.482-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday August 21, 2009  (pediatric pearl day)&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Uniqueness of Neonatal/ Infantile Myocardium compared to adult myocardium&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Neonatal myocardium has a large supply of mitochondria, nuclei and endoplasmic reticulum to support cell growth and protein synthesis but these are non-contractile tissues which render the myocardium stiff and non-compliant. This may impair filling of the left ventricle and limit the ability to increase the cardiac output by increasing stroke volume (Frank Starling mechanism). Stroke volume is therefore relatively fixed and the only way of increasing cardiac output is by increasing heart rate. The cardiac index (defined as the cardiac output related to the body surface area to allow a comparison between different sizes of patients) is increased by 30-60 percent in neonates and infants to help meet the increased oxygen consumption.&lt;br /&gt;&lt;br /&gt;The sympathetic nervous system is not well developed predisposing the neonatal heart to bradycardia. Anatomical closure of the foramen ovale occurs between 3 months and one year of age.&lt;br /&gt;&lt;br /&gt;Neonatal myocardium is distinctly more sensitive to extracellular calcium levels than is mature myocardium. This has been ascribed to the poorly developed sarcoplasmic reticulum of neonatal myocardium and is dependent on serum calcium to maintain optimal contractility. Calcium is an important inotrope in newborns and its optimization is critical in low cardiac output syndrome. &lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-483055091330360512?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/483055091330360512/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/friday-august-21-2009-pediatric-pearl.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/483055091330360512'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/483055091330360512'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/friday-august-21-2009-pediatric-pearl.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-4967505506842998374</id><published>2009-08-20T03:59:00.000-07:00</published><updated>2009-08-19T16:00:04.341-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Thursday August 20, 2009&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Armour Thyroid&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Armour Thyroid is a "natural" thyroid replacement medication that is available by prescription. It is made from thyroid glands of pigs and contains two different thyroid hormones. It provide 38 mcg levothyroxine (T4) and 9 mcg liothyronine (T3) per grain of thyroid.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://4.bp.blogspot.com/_-p7DcK-ba74/SoyDmC7VBFI/AAAAAAAAAlM/LyfPZ9nY9AE/s1600-h/arm.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 400px; DISPLAY: block; HEIGHT: 301px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5371813145190138962" border="0" alt="" src="http://4.bp.blogspot.com/_-p7DcK-ba74/SoyDmC7VBFI/AAAAAAAAAlM/LyfPZ9nY9AE/s400/arm.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-4967505506842998374?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/4967505506842998374/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/thursday-august-20-2009-armour-thyroid.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/4967505506842998374'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/4967505506842998374'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/thursday-august-20-2009-armour-thyroid.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_-p7DcK-ba74/SoyDmC7VBFI/AAAAAAAAAlM/LyfPZ9nY9AE/s72-c/arm.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-4565313721300858907</id><published>2009-08-19T04:36:00.000-07:00</published><updated>2009-08-19T15:58:10.522-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Wednesday August 19, 2009&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;52 year old female presented with headache and vision change. You did retinal exam. Your Diagnosis?&lt;/span&gt;&lt;/em&gt; &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://1.bp.blogspot.com/_-p7DcK-ba74/Sos7Fm8NcPI/AAAAAAAAAlE/01nkssJvC3U/s1600-h/Htretinopathy.jpg"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 400px; DISPLAY: block; HEIGHT: 300px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5371451948107919602" border="0" alt="" src="http://1.bp.blogspot.com/_-p7DcK-ba74/Sos7Fm8NcPI/AAAAAAAAAlE/01nkssJvC3U/s400/Htretinopathy.jpg" /&gt; &lt;/a&gt;&lt;p align="left"&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Hypertensive retinopathy (Malignant phase) &lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;The detection of hypertensive retinopathy with the use of an ophthalmoscope has long been regarded as part of the standard evaluation of persons with hypertension. This clinical practice is supported by both previous and current reports of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC), which list retinopathy as one of several markers of target-organ damage in hypertension.&lt;/p&gt;&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-4565313721300858907?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/4565313721300858907/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/tuesday-august-18-2009-q-52-year-old.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/4565313721300858907'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/4565313721300858907'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/tuesday-august-18-2009-q-52-year-old.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_-p7DcK-ba74/Sos7Fm8NcPI/AAAAAAAAAlE/01nkssJvC3U/s72-c/Htretinopathy.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-8978486584100747259</id><published>2009-08-18T14:23:00.000-07:00</published><updated>2009-08-18T14:24:28.524-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday August 18, 2009&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;Succinylcholine is contraindicated (relatively) for intubation in which  poisoining?&lt;br /&gt;&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Answer:&lt;/span&gt;  &lt;span style="color:#000000;"&gt;Organophosphate poisoining.&lt;br /&gt;&lt;br /&gt;Organophosphate may potentiate effects of succinylcholine. Succinylcholine is relatively contraindicated in Organophosphate poisoining.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-8978486584100747259?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/8978486584100747259/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/tuesday-august-18-2009-q.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/8978486584100747259'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/8978486584100747259'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/tuesday-august-18-2009-q.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-6442599462255799668</id><published>2009-08-17T11:24:00.001-07:00</published><updated>2009-08-17T16:44:03.304-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Monday August 17, 2009&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Q&lt;/span&gt;; &lt;em&gt;&lt;span style="color:#003333;"&gt;Is menstrual bleeding a contraindication to thrombolytic therapy in Acute MI or Stroke?&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Answer&lt;/span&gt;: &lt;span style="color:#000000;"&gt;No&lt;br /&gt;&lt;br /&gt;There may be a clinically significant increase in the risk of moderate bleeding during menstruation. But lifesaving benefit of thrombolytic therapy for acute myocardial infarction should generally not be withheld because of active menstruation. Potential patients should be advised that they might require transfusion for increased menstrual flow.&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-6442599462255799668?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/6442599462255799668/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-17-2009-q-is-menstrual.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/6442599462255799668'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/6442599462255799668'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-17-2009-q-is-menstrual.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-9113794330111465800</id><published>2009-08-16T14:13:00.000-07:00</published><updated>2009-08-16T14:14:35.823-07:00</updated><title type='text'></title><content type='html'>&lt;p&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;&lt;span style="color:#000066;"&gt;Sunday August 16, 2009&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Causes of False-Positive Troponin Results (Lab interference / errors)&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Heterophile antibodies &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Human anti-mouse antibodies &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Autoantibodies &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Fibrin clots &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Rheumatoid factor &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Microparticles in specimen &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Interference by endogenous components in blood (bilirubin, hemoglobin, lipemia) &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;High concentration of alkaline phosphatase &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Immunocomplex formation &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Analyzer malfunction&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-9113794330111465800?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/9113794330111465800/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-16-2009-causes-of-false.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/9113794330111465800'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/9113794330111465800'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-16-2009-causes-of-false.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-3234790086280834844</id><published>2009-08-15T09:37:00.000-07:00</published><updated>2009-08-15T09:37:00.314-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday August 15, 2009&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Ramsay Sedation Scale&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Clinical Score depending on  Level of Sedation Achieved&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003300;"&gt;6&lt;/span&gt; - Asleep, no response&lt;br /&gt;&lt;span style="color:#003333;"&gt;5&lt;/span&gt; -  Asleep, sluggish response to light glabellar tap or loud auditory stimulus&lt;br /&gt;&lt;span style="color:#003333;"&gt;4 -&lt;/span&gt; Asleep, but with brisk response to light glabellar tap or loud auditory stimulus&lt;br /&gt;&lt;span style="color:#003333;"&gt;3&lt;/span&gt; - Patient responds to commands&lt;br /&gt;&lt;span style="color:#003333;"&gt;2 - &lt;/span&gt; Patient cooperative, oriented, and tranquil&lt;br /&gt;&lt;span style="color:#003333;"&gt;1 - &lt;/span&gt; Patient anxious, agitated, or restless&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-3234790086280834844?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/3234790086280834844/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-15-2009-ramsay-sedation.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3234790086280834844'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3234790086280834844'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-15-2009-ramsay-sedation.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-5701696006970471175</id><published>2009-08-14T10:35:00.000-07:00</published><updated>2009-08-14T10:35:00.412-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Friday August 14, 2009&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt; &lt;span style="color:#000066;"&gt;(pediatric pearl)&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Uniqueness of Pediatric Upper Airway &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Previous related pearls:&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;a href="http://08-2009-icuroom.blogspot.com/2009_08_07_archive.html"&gt;&lt;span style="color:#660000;"&gt;&lt;em&gt;Uniqueness of Pediatric Lower Airway - Part 1&lt;br /&gt;Uniqueness of Pediatric Lower Airway - Part 2&lt;/em&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#660000;"&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;p align="left"&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;The frequency of acute respiratory failure is higher in infants and young children than in adults for several reasons. This difference can be explained by defining anatomic compartments and their developmental differences in pediatric patients that influence susceptibility to acute respiratory failure.&lt;br /&gt;&lt;br /&gt;The extrathoracic airway (extending from the nose to the subglottic region of the trachea) has significant differences in pediatric versus adult patients include the following: &lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt; &lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Neonates and infants are obligate nasal breathers until the age of 2-6 months because of the proximity of the epiglottis to the nasopharynx. Nasal congestion can lead to clinically significant distress in this age group. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;The small size of the airway is one of the primary differences in infants and children younger than 8 years compared with older patients. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Infants and young children have a large tongue that fills a small oropharynx. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Infants and young children have a cephalic larynx. The larynx is opposite vertebrae C3-4 in children versus C6-7 in adults. Larynx cone-shaped: narrowest at subglottic cricoid ring - Softer, more pliable: may be gently flexed or rotated anteriorly &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;The epiglottis is larger and more horizontal to the pharyngeal wall in children than in adults. The cephalic larynx and large epiglottis can make laryngoscopy challenging. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Vocal cords slanted: anterior commissure more inferior &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Infants and young children have a narrow subglottic area. In children, the subglottic area is cone shaped, with the narrowest area at the cricoid ring. A small amount of subglottic edema can lead to clinically significant narrowing, increased airway resistance, and increased work of breathing. Older patients and adults have a cylindrical airway that is narrowest at the glottic opening. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;In slightly older children, adenoidal and tonsillar lymphoid tissue is prominent and can contribute to airway obstruction. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Upper airway contributes 50% to total airway resistance compared to about 20% in adults. &lt;/strong&gt;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Infant head is relatively larger: naturally flexed in supine position. Extension of head may result in tracheal extubation; while flexion may lead to main stem intubation.&lt;/strong&gt; &lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-5701696006970471175?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/5701696006970471175/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/friday-august-14-2009-pediatric-pearl.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/5701696006970471175'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/5701696006970471175'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/friday-august-14-2009-pediatric-pearl.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-615598771686018443</id><published>2009-08-13T10:25:00.000-07:00</published><updated>2009-08-13T10:27:53.887-07:00</updated><title type='text'></title><content type='html'>&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday August 13, 2009&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;KING LT (laryngeal tube) intubation&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/div&gt;&lt;img id="BLOGGER_PHOTO_ID_5369501052352904146" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 376px; CURSOR: hand; HEIGHT: 300px; TEXT-ALIGN: center" alt="" src="http://1.bp.blogspot.com/_-p7DcK-ba74/SoRMwh6Uu9I/AAAAAAAAAk8/8NA4nYckCHQ/s400/KINg.jpg" border="0" /&gt; &lt;p align="left"&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;The king airway is a blind insertion, just like combi tube. It's a double lumen airway. It occludes the esophagous and ventilates through the opening on the side of the tube. King LT is an advanced airway where ventilations through it go into the trachea, and the esophagus is occluded.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/ryyHWewl5ho&amp;amp;color1=" color2="0xcfcfcf&amp;amp;hl=" feature="player_embedded&amp;amp;fs=" width="425" height="344" type="application/x-shockwave-flash" allowfullscreen="true" allowscriptaccess="always"&gt;&lt;/embed&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-615598771686018443?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/615598771686018443/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/thursday-august-13-2009-king-lt.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/615598771686018443'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/615598771686018443'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/thursday-august-13-2009-king-lt.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_-p7DcK-ba74/SoRMwh6Uu9I/AAAAAAAAAk8/8NA4nYckCHQ/s72-c/KINg.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-5798526653167851080</id><published>2009-08-12T19:35:00.000-07:00</published><updated>2009-08-11T19:37:31.582-07:00</updated><title type='text'></title><content type='html'>&lt;span style="font-size:180%;color:#660000;"&gt;&lt;div align="center"&gt;&lt;span style="font-family:'Arial','sans-serif';font-size:10;"&gt;&lt;span style="color:#000000;"&gt;&lt;span style="font-size:0;"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;p class="MsoNormal" style="MARGIN: 0in 0in 0pt 0.5in" align="center"&gt;&lt;span style="font-family:'Arial','sans-serif';font-size:100%;"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="font-family:Arial;font-size:100%;color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Wednesday August 12, 2009&lt;br /&gt; Fluid Resuscitation and Intra-Abdominal Hypertension&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;embed src="http://www.youtube.com/v/8hKxmi-QVwA&amp;amp;hl=" width="425" height="344" type="application/x-shockwave-flash" fs="1&amp;amp;" allowfullscreen="true" allowscriptaccess="always"&gt;&lt;/embed&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-5798526653167851080?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/5798526653167851080/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/wednesday-august-12-2009-fluid.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/5798526653167851080'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/5798526653167851080'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/wednesday-august-12-2009-fluid.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-7826659974577078400</id><published>2009-08-11T19:25:00.000-07:00</published><updated>2009-08-12T14:11:29.689-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Tuesday, August 11, 2009&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Intracerebroventricular Administration of Drugs&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/strong&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Reference:&lt;/span&gt;&lt;span style="color:#000000;"&gt; Cook AM, et al. Pharmacotherapy 2009;29(7):832&lt;/span&gt;&lt;/em&gt;&lt;span style="color:#000000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;Guidelines do not currently exist for drug administration via the intracerebroventricular route, however, a good review was just published in Pharmacotherapy.&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Methods of administration include:&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;· &lt;em&gt;Directly into the lumbar cistern (thecal sac), Intrathecally&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;o Low risk and easily performed at bedside, however, requires separate puncture for subsequent doses which increases risk of infection&lt;br /&gt;&lt;br /&gt;· &lt;em&gt;Directly into the lateral ventricle&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;o Repeated taps not routinely performed due to risk of neurovascular injury or intracranial hemorrhage&lt;br /&gt;&lt;br /&gt;· &lt;em&gt;Permanent access through implanted catheter connected to reservoir&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;o e.g. Ommaya reservoir&lt;br /&gt;&lt;br /&gt;· &lt;em&gt;Ventriculostomy &lt;/em&gt;&lt;br /&gt;&lt;br /&gt;o Ideal for situations requiring limited time for CSF drainage or intraventricular drug administration. Should use caution and close monitoring of intracranial pressure&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Considerations for drug administration:&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;em&gt;· Volume of solution&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;o Affects the distribution or clearance of drug. Increasing volume would result in an alteration in the normal intracranial components to maintain normal intracranial pressure.&lt;br /&gt;&lt;br /&gt;· &lt;em&gt;Rate of instillation&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;o Slow instillation recommended to allow for extracellular fluid displacement to prevent tissue damage. Recommend small volumes &lt;3ml&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-7826659974577078400?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/7826659974577078400/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/intracerebroventricular-administration.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/7826659974577078400'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/7826659974577078400'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/intracerebroventricular-administration.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-3038875301636615528</id><published>2009-08-10T19:16:00.001-07:00</published><updated>2009-08-30T16:30:41.304-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Monday August 10, 2009&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Quick and Dirty on Vasopressors and Inotropes&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;&lt;span style="color:#660000;"&gt;Vasopressor activity on the following receptors are agonistic:&lt;/span&gt; &lt;/span&gt;&lt;/em&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;&lt;ul&gt;&lt;li&gt;&lt;/span&gt;&lt;/em&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;a1 receptors&lt;/em&gt;&lt;/span&gt;-- peripheral arteries-- peripheral vasoconstriction &lt;/li&gt;&lt;li&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;b1 receptors&lt;/em&gt;&lt;/span&gt;-- coronary smooth muscle-- increased heart rate and contractility &lt;/li&gt;&lt;li&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;b2 receptors&lt;/em&gt;&lt;/span&gt;—smooth muscle—increases force of contractility in the heart &lt;/li&gt;&lt;li&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;DA1 receptors&lt;/em&gt;&lt;/span&gt;-- renal, mesenteric, and coronary beds-- vasodilation and increase urine output. &lt;/li&gt;&lt;li&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;V1, receptors&lt;/span&gt;&lt;/em&gt;-- vascular smooth muscle--vasopressor; &lt;/li&gt;&lt;li&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;V2 receptors&lt;/em&gt;&lt;/span&gt;-- renal collecting duct system--natural diurectic&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;Vasopressors:&lt;/span&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;Dopamine&lt;/span&gt;&lt;/em&gt;: receptor action is dependent on dose…&lt;em&gt;    DA1&lt;/em&gt; 1-5 microgram/kg/min + HR; &lt;em&gt;b1&lt;/em&gt; 5-10 microgram/kg/min, ++ HR,  + MAP,  + CO; &lt;em&gt;a1&lt;/em&gt; &gt; 10 microgram/kg/min + SVR,  + MAP, + HR,  +CO &lt;/li&gt;&lt;li&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Epinephrine&lt;/span&gt;&lt;/em&gt;: &lt;em&gt;b1 &gt;&gt; a1&lt;/em&gt; 1-20 microgram/min ++ SVR, +MAP, +HR, +CO&lt;/li&gt;&lt;li&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Norepinephrine&lt;/span&gt;&lt;/em&gt;:&lt;em&gt; a1 &gt; b1&lt;/em&gt; 1-80 microgram/min, ++ SVR, ++MAP , ?+HR, ?+CO &lt;/li&gt;&lt;li&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;Phenylephrine&lt;/em&gt;&lt;/span&gt;: &lt;em&gt;a1&lt;/em&gt; 2-200 micrograms/min; ++SVR, +MAP, ?+HR, ?+ CO &lt;/li&gt;&lt;li&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Vasopressin&lt;/span&gt;&lt;/em&gt;: &lt;em&gt;V1 V2&lt;/em&gt; 0.04 units/min  ++SVR, +MAP, ?+HR, ? +CO&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#660000;"&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;span style="color:#660000;"&gt;Inotropes:&lt;/span&gt; &lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Dobutamine&lt;/span&gt;&lt;/em&gt;: b1, b2 2-20 microgram/kg/min ááCO áHR âSVR ?âMAP&lt;/li&gt;&lt;li&gt;&lt;em&gt;&lt;span style="color:#003333;"&gt;Milrinone:&lt;/span&gt;&lt;/em&gt; PDE inhibitor in vascular and cardiac smooth muscle which improves calcium handling causing dilation. In cardiac muscle, the inhibition of phosphodiesterase results in increased levels of cAMP, resulting in increased chronotropic and inotropic effects.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Reference:&lt;br /&gt;&lt;br /&gt;Dellinger RP. Crit Care Med 2008;36(1):296&lt;/span&gt; &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-3038875301636615528?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/3038875301636615528/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-10-2009-quick-and-dirty.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3038875301636615528'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3038875301636615528'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-10-2009-quick-and-dirty.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-8496972625531755126</id><published>2009-08-09T10:35:00.000-07:00</published><updated>2009-08-09T10:37:59.604-07:00</updated><title type='text'></title><content type='html'>&lt;div align="center"&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday August 9, 2009&lt;/span&gt;&lt;br /&gt; &lt;span style="color:#660000;"&gt;Picture Diagnosis&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;strong&gt; &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;em&gt;What is your diagnosis?&lt;br /&gt;&lt;br /&gt;Hint is Arrow&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;/div&gt;.&lt;br /&gt;&lt;img id="BLOGGER_PHOTO_ID_5368019169005318482" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 320px; CURSOR: hand; HEIGHT: 320px; TEXT-ALIGN: center" alt="" src="http://4.bp.blogspot.com/_-p7DcK-ba74/Sn8I_kQMsVI/AAAAAAAAAk0/rQBQQnJoDB0/s400/ptcl.bmp" border="0" /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Answer:&lt;/span&gt; Pneumothorax after central line placement.&lt;br /&gt;&lt;br /&gt;Note the abnormally placed central line extending upwards from subclavian vein into internal jugular vein along with pneumothorax&lt;/span&gt;&lt;/strong&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-8496972625531755126?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/8496972625531755126/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-9-2009-picture-diagnosis.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/8496972625531755126'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/8496972625531755126'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-9-2009-picture-diagnosis.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_-p7DcK-ba74/Sn8I_kQMsVI/AAAAAAAAAk0/rQBQQnJoDB0/s72-c/ptcl.bmp' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-3882231672893590942</id><published>2009-08-08T10:46:00.000-07:00</published><updated>2009-08-08T10:47:49.253-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Saturday August 8, 2009&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Q;&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;Troponins, once secreted, remains elevated for how many days? &lt;/span&gt;&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;Answer:&lt;/span&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;Troponin, once secreted, remains elevated for 7-10 days.&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://3.bp.blogspot.com/_-p7DcK-ba74/Sn26CZluexI/AAAAAAAAAks/tEFrytX1lj0/s1600-h/cardenz.gif"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 357px; DISPLAY: block; HEIGHT: 244px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5367650881287125778" border="0" alt="" src="http://3.bp.blogspot.com/_-p7DcK-ba74/Sn26CZluexI/AAAAAAAAAks/tEFrytX1lj0/s400/cardenz.gif" /&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-3882231672893590942?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/3882231672893590942/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-8-2009-q-troponins-once.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3882231672893590942'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3882231672893590942'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-8-2009-q-troponins-once.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_-p7DcK-ba74/Sn26CZluexI/AAAAAAAAAks/tEFrytX1lj0/s72-c/cardenz.gif' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-779561802639714305</id><published>2009-08-07T22:43:00.000-07:00</published><updated>2009-08-08T10:51:36.114-07:00</updated><title type='text'></title><content type='html'>&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;&lt;strong&gt;Friday August 7, 2009&lt;/strong&gt; &lt;em&gt;(pediatric pearl)&lt;/em&gt;&lt;/span&gt;&lt;em&gt;&lt;br /&gt;&lt;/em&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Uniqueness of Pediatric Lower Airway - Part 2&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;em&gt;(see Uniqueness of Pediatric Lower Airway - Part 1&lt;span style="color:#660000;"&gt; &lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;/span&gt;&lt;a href="http://07-09-icuroom.blogspot.com/2009_07_31_archive.html" target="_blank"&gt;&lt;strong&gt;&lt;em&gt;&lt;span style="color:#660000;"&gt;here&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;em&gt;)&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The frequency of acute respiratory failure is higher in infants and young children than in adults for several reasons. This difference can be explained by defining anatomic compartments and their developmental differences in pediatric patients that influence susceptibility to acute respiratory failure. &lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;br /&gt;The intrathoracic airways and lung include the conducting airways and alveoli, the interstitia, the pleura, the lung lymphatics, and the pulmonary circulation. Noteworthy differences among pediatric children include the following:&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;br /&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Infants and young children have fewer alveoli than do adults. The number dramatically increases during childhood, from approximately 20 million after birth to 300 million by 8 years of age. Therefore, infants and young children have a relatively small area for gas exchange. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;The alveolus is small. Alveolar size increases from 150-180 to 250-300 µm during childhood. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Collateral ventilation is not fully developed; therefore, atelectasis is more common in children than in adults. During childhood, anatomic channels form to provide collateral ventilation to alveoli. These pathways are between adjacent alveoli (pores of Kohn), bronchiole and alveoli (Lambert channel), and adjacent bronchioles. This important feature allows alveoli to participate in gas exchange even in the presence of an obstructed distal airway. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Smaller intrathoracic airways are more easily obstructed than larger ones. With age, the airways enlarge in diameter and length. &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Infants and young children have relatively little cartilaginous support of the airways. As cartilaginous support increases, dynamic compression during high expiratory flow rates is prevented.&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-779561802639714305?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/779561802639714305/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/friday-august-7-2009-pediatric-pearl.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/779561802639714305'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/779561802639714305'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/friday-august-7-2009-pediatric-pearl.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-8039298676731755090</id><published>2009-08-06T23:56:00.000-07:00</published><updated>2009-08-08T10:59:49.229-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Thursday August 6, 2009&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Heparin Induced HyperKalemia&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Hyperkalemia from Heparin is a well know phenomenon and has been detected particularly on geriatric, renal insufficient and diabetic patients. Hyperkalemia can be anywhere from .3 to 1.7 mEq/Litre. It usually occurs around on day 3 with SQ heparin (as for DVT prophylaxis) but can occur early with IV heparin &lt;span style="font-size:78%;"&gt;1,2,3,4.&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="font-size:78%;"&gt; &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Hyperkalemia has been reported with low- molecular weight heparins too but risk is low &lt;span style="font-size:78%;"&gt;5, 6, 7.&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Mechanism of action:&lt;/span&gt; Heparin induce hypoaldosteronism and can subsequently lead to hyperkalemia &lt;span style="font-size:78%;"&gt;6.&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#660000;"&gt;&lt;strong&gt;Treatment&lt;/strong&gt;: &lt;span style="color:#000000;"&gt;&lt;strong&gt;Best thing is to discontinue the culprit but if heparin is absolutely required, fludrocortisone (.1 mg/day) has been reported to be effective in heparin-induced hyperkalemia&lt;/strong&gt;&lt;/span&gt; &lt;span style="font-size:78%;"&gt;8.&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: Click to get abstracts/articles&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://ats.ctsnetjournals.org/cgi/content/full/74/5/1698" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Case report - Heparin-induced hyperkalemia after cardiac surgery&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Ann Thorac Surg 2002;74:1698-1700&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2. &lt;/span&gt;&lt;a href="http://www.theannals.com/cgi/content/abstract/24/3/244" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Heparin-induced hyperkalemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; -The Annals of Pharmacotherapy: Vol. 24, No. 3, pp. 244-246.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;3. &lt;/span&gt;&lt;a href="http://www.endocrine-abstracts.org/ea/0004/ea0004p26.htm" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Heparin Induced HyperKalemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Endocrine Abstracts (2002) 4 P26&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;4. &lt;/span&gt;&lt;a href="http://www.amjphysmedrehab.com/pt/re/ajpmr/abstract.00002060-200001000-00019.htm;jsessionid=EeI2wAT53phP4F3U0EMxZzYELAgaICWOuTNGLK1o3hzIEPFmWCha!-839643570!-949856144!9001!-1" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Heparin-Induced Hyperkalemia Confirmed by Drug Rechallenge&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;. American Journal of Physical Medicine &amp;amp; Rehabilitation. 79(1):93-96, January/February 2000.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;5. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;amp;amp;amp;db=PubMed&amp;amp;list_uids=15133781&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Pharmacoepidemiol Drug Saf.2004 May;13(5):299-302.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;6. Effect of Low-Molecular-Weight Heparin on Potassium Homeostasis - Pathophysiology of Haemostasis and Thrombosis 2002;32:107-110&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;7. &lt;/span&gt;&lt;a href="http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijgg/vol2n2/heparin.xml" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Low Molecular Weight Heparins Can Lead To Hyperkalaemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; The Internet Journal of Geriatrics and Gerontology . 2005. Volume 2 Number 2.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;8. &lt;/span&gt;&lt;a href="http://www.theannals.com/cgi/content/abstract/34/5/606" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Fludrocortisone for the treatment of heparin-induced hyperkalemia&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - The Annals of Pharmacotherapy: Vol. 34, No. 5, pp. 606-610 &lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-8039298676731755090?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/8039298676731755090/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/thursday-august-6-2009-heparin-induced.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/8039298676731755090'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/8039298676731755090'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/thursday-august-6-2009-heparin-induced.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-3346878100606668447</id><published>2009-08-05T20:59:00.000-07:00</published><updated>2009-08-08T11:03:32.854-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Wednesday August 5, 2009&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Scenario:&lt;/span&gt; &lt;em&gt;&lt;span style="color:#003333;"&gt;25 year old patient presented to the emergency room with complaint of 2 days history of muscular weakness which is symmetric and descending and diplopia. He denies any fever or chills. He does give the history of having injury to the face. He works as marine driller. His symptoms are progressively getting worse. His vitals signs reveal no fever, and bradycardia with the heart rate of 48 and blood pressure of 120/80 mm hg. His Slow vital capacity was 1 liter (33% of predicted). He was admitted in intensive care unit.&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Diagnosis:&lt;/span&gt; Botulism (110 cases in US per year with 3 percent being wound Botulism)&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#660000;"&gt;Differential diagnosis:&lt;/span&gt; Mysthenia Gravis, Lambert-Eaton syndrome, Guillain-Barre’s syndrome, poliolmyelitis, Ticks paralysis, heavy metal intoxication.&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;Botulism has an acute onset with bilateral cranial neuropathies and symmetric descending weakness. Key feature include: &lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Patient is afebrile &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Symmetric neurological deficit &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Patient is responsive &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Normal or slow heart rate and normal blood pressure &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;No sensory deficit &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Blurred vision&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#660000;"&gt;Treatment:&lt;/span&gt; &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Equine serum botulism antitoxin &lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Penicillin G intravenously 3 grams every 4 hours&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-3346878100606668447?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/3346878100606668447/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/wednesday-august-5-2009-scenario-25.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3346878100606668447'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3346878100606668447'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/wednesday-august-5-2009-scenario-25.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-1644926465699657246</id><published>2009-08-04T22:09:00.000-07:00</published><updated>2009-08-08T10:54:29.224-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Tuesday August 4, 2009&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#990000;"&gt;Heparin rebound phenomenon&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#000000;"&gt;&lt;strong&gt;Heparin rebound phenomenon, is considered to be a contributive factor in excessive postoperative bleeding after cardiac surgery. It is due to the reappearance of anticoagulant activity despite adequate neutralization with protamine.This phenomenon is well known since atleast last 45 years &lt;span style="font-size:78%;"&gt;1&lt;/span&gt;.&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;The underlying etiology is due to the fact that a significant amount of heparin remains bound to plasma proteins and escape neutralization by protamine. Later this heparin get released and may contribute to excessive postoperative bleeding after cardiac surgery. Though logically, the treatment is more administration of prtoamine but caution should be taken as high and inappropriate protamine dose may lead to 'acute' pulmonary hypertension &lt;span style="font-size:78%;"&gt;2&lt;/span&gt; and interestingly failed to show decrease in blood product adminstration&lt;span style="font-size:78%;"&gt; 3&lt;/span&gt; or any difference in the thrombelastographic profiles or coagulation screen (PT, PTT, ACT and platelets) &lt;span style="font-size:78%;"&gt;2&lt;/span&gt;. Also life threatening protamine reactions is another risk need to be considered &lt;span style="font-size:78%;"&gt;5.&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#003333;"&gt;Note:&lt;/span&gt; &lt;span style="color:#000000;"&gt;This Heparin rebound phenomenon is different from Rebound increase in Thrombin Generation and Activity after cessation of intravenous heparin in patients with acute coronary syndromes which is also often referred as heparin rebound phenomenon&lt;/span&gt;&lt;span style="font-size:78%;"&gt; 4.&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: click to get abstract/article&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=14450355&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Heparin rebound phenomenon in extracorporeal circulation&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Surg Gynecol Obstet.1962 Aug;115:191-8.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2.&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=1606290&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Heparin rebound phenomenon--much ado about nothing?&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Blood Coagul Fibrinolysis. 1992 Apr;3(2):187-91.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;3. &lt;/span&gt;&lt;a href="http://jtcs.ctsnetjournals.org/cgi/content/abstract/128/2/211" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - J Thorac Cardiovasc Surg 2004;128:211-219&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;4. &lt;/span&gt;&lt;a href="http://circ.ahajournals.org/cgi/content/full/91/7/1929" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Rebound Increase in Thrombin Generation and Activity After Cessation of Intravenous Heparin in Patients With Acute Coronary Syndromes &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- Circulation. 1995;91:1929-1935.&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;5. &lt;/span&gt;&lt;a href="http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijtcvs/vol7n1/protamine.xml" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Life Threatening Protamine Reactions In Cardiac Surgery: Literature Review With A Case Report&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - The Internet Journal of Thoracic and Cardiovascular Surgery. 2005. Volume 7 Number 1. &lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-1644926465699657246?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/1644926465699657246/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/tuesday-august-4-2009-heparin-rebound.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/1644926465699657246'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/1644926465699657246'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/tuesday-august-4-2009-heparin-rebound.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-5394817403490498593</id><published>2009-08-03T22:20:00.000-07:00</published><updated>2009-08-08T10:49:57.916-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;span style="color:#000066;"&gt;Monday August 3, 2009&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Atenolol in renal failure&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;One must use caution while prescribing atenolol to patients with renal insufficiency. The elimination half-life of atenolol is extensively prolonged in patient with renal failure. The normal half life of atenolol is 6 to 7 hours; however, in renal failure patients the half-life may be extended to more than 100 hours &lt;span style="font-size:78%;"&gt;2&lt;/span&gt;.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;The recommended dosage are following:&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;CrCl 35 mL/min or greater - normal dosing&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;CrCl 15 - 35 mL/min - MAX. dose 50 mg orally QD&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;CrCl less than 15 mL/min - MAX. dose 25 mg orally QD&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Hemodialysis: 25-50 mg orally after each dialysis session.&lt;/span&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;Treatment of atenolol overdose in a patient with renal failure is recommended with serial hemodialysis and charcoal hemoperfusion &lt;span style="font-size:78%;"&gt;3&lt;/span&gt;. On the contrary, metoprolol is extensively metabolized via the hepatic system.&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;References: &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;1.&lt;/span&gt;&lt;a href="http://www.rxlist.com/cgi/generic/atenolol_ids.htm#D" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Atenolol-DOSAGE AND ADMINISTRATION &lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt;- rxlist.com&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;2.&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=7408390&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Atenolol kinetics in renal failure&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; - Clin Pharmacol Ther. 1980 Sep;28(3):302-9&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="font-size:78%;color:#003333;"&gt;3. &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=10928688&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;span style="font-size:78%;color:#003333;"&gt;Treatment of atenolol overdose in a patient with renal failure using serial hemodialysis and hemoperfusion and associated echocardiographic findings&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:78%;color:#003333;"&gt; Vet Hum Toxicol. 2000 Aug;42(4):224-5.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-5394817403490498593?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/5394817403490498593/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-3-2009-atenolol-in-renal.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/5394817403490498593'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/5394817403490498593'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/monday-august-3-2009-atenolol-in-renal.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-3109244939930273372</id><published>2009-08-02T03:53:00.000-07:00</published><updated>2009-08-02T03:53:00.481-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Sunday August 2, 2009&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Why Arixtra doesn't cause HIT (Heparin induced thrombocytopenia)&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://3.bp.blogspot.com/_-p7DcK-ba74/SnQe1nmOMSI/AAAAAAAAAkk/ayMb44C-rUU/s1600-h/arix.gif"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 364px; DISPLAY: block; HEIGHT: 400px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5364946962616299810" border="0" alt="" src="http://3.bp.blogspot.com/_-p7DcK-ba74/SnQe1nmOMSI/AAAAAAAAAkk/ayMb44C-rUU/s400/arix.gif" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000000;"&gt;ARIXTRA (Fondaparinux) is not a heparin. ARIXTRA is the first and only pentasaccharide antithrombotic agent inhibiting only factor Xa&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-3109244939930273372?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/3109244939930273372/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-2-2009-why-arixtra-doesnt.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3109244939930273372'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/3109244939930273372'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/sunday-august-2-2009-why-arixtra-doesnt.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_-p7DcK-ba74/SnQe1nmOMSI/AAAAAAAAAkk/ayMb44C-rUU/s72-c/arix.gif' height='72' width='72'/><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-5664917384681228257.post-6368269440493072021</id><published>2009-08-01T00:08:00.000-07:00</published><updated>2009-08-01T03:46:08.623-07:00</updated><title type='text'></title><content type='html'>&lt;strong&gt;&lt;span style="color:#000066;"&gt;Saturday August 1, 2009 &lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000066;"&gt;&lt;/span&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#990000;"&gt;Procedure tip - Straight to Cuff Stylet Shaping&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;object width="425" height="344"&gt;&lt;param name="movie" value="http://www.youtube.com/v/7ps3IDquCRE&amp;amp;color1=0xb1b1b1&amp;amp;color2=0xcfcfcf&amp;amp;hl=en&amp;amp;feature=player_embedded&amp;amp;fs=1"&gt;&lt;param name="allowFullScreen" value="true"&gt;&lt;param name="allowScriptAccess" value="always"&gt;&lt;embed src="http://www.youtube.com/v/7ps3IDquCRE&amp;color1=0xb1b1b1&amp;color2=0xcfcfcf&amp;hl=en&amp;feature=player_embedded&amp;fs=1" type="application/x-shockwave-flash" allowfullscreen="true" allowscriptaccess="always" width="425" height="344"&gt;&lt;/embed&gt;&lt;/object&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5664917384681228257-6368269440493072021?l=08-2009-icuroom.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://08-2009-icuroom.blogspot.com/feeds/6368269440493072021/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-1-2009-procedure-tip.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/6368269440493072021'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/5664917384681228257/posts/default/6368269440493072021'/><link rel='alternate' type='text/html' href='http://08-2009-icuroom.blogspot.com/2009/08/saturday-august-1-2009-procedure-tip.html' title=''/><author><name>ICU room Pearls</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>
